Dr. Cardineau began his career in the field of Agricultural Biotechnology in 1983 as a Scientist at a small start-up company, Sungene Technologies, where he also served a short time as Manager of Market Development. He moved to Agrigenetics in 1989 as Manager and then Director of Molecular Biology. In 1993 Agrigenetics was acquired by Mycogen Corporation and Dr. Cardineau assumed responsibility as Director for the merged Molecular Biology groups and eventually for Biochemistry as well. In 1996 he became Director, Technology Development, involved in strategic planning and implementation regarding Intellectual Property and the identification, evaluation and acquisition of technology directed toward future product development. He received the Mycogen President’s Award in 1996 and 1998 for his contributions to the company. Dow AgroSciences acquired Mycogen in 1998 and Dr. Cardineau returned to research assuming the positions of Global Leader R&D, Output Agriculture Gene Discovery and Site Leader for the San Diego, CA, Research Facility. In 2002 he became Global Leader for Science and Technology with responsibilities involved in strategic research planning. He received a Dow AgroSciences Inventors Award in 1998, 1999, 2000, 2001 and 2002. His efforts, collectively with members of his research team, have resulted in several agricultural biotechnology products in the market place and in commercial development, including Herculex Insect Resistant Corn, Widestrike Cotton and the first transgenic plant made pharmaceutical approved and licensed by a regulatory authority any place in the world, a Newcastle Disease Virus subunit vaccine produced in tobacco cell culture, for which he received a Dow Vision Award in 2006.
Cardineau left DAS in the fall of 2002 and in January 2003 became a Research Professor at Arizona State University with appointments in the Center for Infectious Diseases and Vaccinology of the Biodesign Institute, the School of Life Sciences and the Sandra Day O’Connor College of Law. He was awarded the Associated Students of Arizona State University Centennial Professorship for 2008-2009 in April of 2008 for his contributions to teaching and to mentoring his students. His academic credentials include an A.B. in American Civilization, a B.S. in Microbiology and a Ph.D. in Molecular and Cellular Biology. He has co-authored numerous scientific papers and has been included in a number of Who’s Who listings as well as Men and Women of Science. He served on the Science Advisory Board for the County of San Diego, CA, and currently serves on the Advisory Boards of ASU Technopolis and The Technology Ventures Clinic at AzTE, is an advisor and consultant to the start-up biotechnology companies ERAbiotech, iDiverse, Algal Technologies and Sonora Transplants, is member of the Flinn Foundation BioAgriculture Research/Technology Platform Committee for Arizona and serves the United States Secretary of Agriculture as a member of the Advisory Committee on Biotechnology and 21st Century Agriculture (AC21). He is an inventor of 21 issued and 14 published pending US patent applications in the plant sciences, with over 60 patents and applications world wide, including broad enabling patents describing the earliest production of vaccines in transgenic plants, the synthesis of genes to improve their expression in a foreign host and the only plant made vaccine approved by a regulatory authority for commercial release.